sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
18-Apr-2014 07:46
US Eastern Time




Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books



Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation


Submit a Calendar Item


Links & Resources


RSS Feeds

Accessibility Option On


Portal Home


Background Articles

Research Papers


Links & Resources

Portal: Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 626-650 out of 901.

<< < 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 > >>

Public Release: 26-Oct-2012
Trial of HIV test for babies in Africa could make a big difference
Today, mothers in Africa sometimes walk more than 10 miles to a clinic only to learn that conventional HIV test results for their babies are not available yet. Soon residents in Maputo, Mozambique, will participate in the first clinical trial of a new HIV test developed at Northwestern University that will deliver a diagnosis in less than an hour. The test could dramatically improve the rates in which infected infants are diagnosed and treated.
Bill & Melinda Gates Foundation

Contact: Megan Fellman
Northwestern University

Public Release: 26-Oct-2012
New grant to establish pan-continental bioinformatics research network in Africa
Victor Jongeneel, director of the High-Performance Biological Computing program and affiliate of the Institute for Genomic Biology and the National Center for Supercomputing Applications at the University of Illinois, is a key participant in a grant awarded by the Human Heredity and Health in Africa Initiative, or H3Africa, to establish a pan-continental bioinformatics network to aid research.
Human Heredity and Health in Africa Initiative

Contact: Nicholas Vasi
Institute for Genomic Biology, University of Illinois at Urbana-Champaign

Public Release: 25-Oct-2012
Students win $100K for 3-D printer to turn waste plastic into composting toilets, rainwater systems
Three undergraduates won $100,000 to form a company that will work with partners in Oaxaca, Mexico, to build giant 3-D printers that can transform waste plastic into composting toilets and pieces for rainwater harvesting systems.

Contact: Hannah Hickey
University of Washington

Public Release: 25-Oct-2012
Proceedings of the National Academy of Sciences
New opportunity for rapid treatment of malaria
Researchers have identified a new means to eradicate malaria infections by rapidly killing the blood-borne Plasmodium parasites that cause the disease.
New York Pasteur Foundation, Bill and Melinda Gates Foundation

Contact: Simon Levey
Imperial College London

Public Release: 25-Oct-2012
Scientists to study the role genes play in treating TB
The University of Liverpool has been awarded funding to determine whether differences in our genes determine how patients respond to drugs used to treat Tuberculosis in Sub-Saharan Africa.
H3Africa project

Contact: Sarah Stamper
University of Liverpool

Public Release: 25-Oct-2012
Scientists create first mouse model of typhoid fever
Researchers have created the first true mouse model of typhoid infection. The development promises to advance the study of typhoid and the creation of new vaccines against the infection, which remains a major health threat in developing countries.
National Institutes of Health

Contact: Karin Eskenazi
Columbia University Medical Center

Public Release: 25-Oct-2012
Structure discovered for promising tuberculosis drug target
Researchers at Johns Hopkins have figured out the three-dimensional shape of the protein responsible for creating unique bonds within the cell wall of the bacteria that cause tuberculosis. The bonds make the bacteria resistant to currently available drug therapies, contributing to the alarming rise of these super-bacteria throughout the world.
National Institutes of Health, NIH/National Institute of Allergy and Infectious Diseases

Contact: Catherine Kolf
Johns Hopkins Medicine

Public Release: 25-Oct-2012
An animal model of typhoid fever could lead to better vaccines
The first mouse model of the common bacterial disease typhoid fever is reported in a study published by Cell Press Oct. 25 in the journal Cell. Because the animals show human-like symptoms and respond positively to immunization, they could be used to develop more effective vaccines against the deadly pathogen.

Contact: Elisabeth (Lisa) Lyons
Cell Press

Public Release: 24-Oct-2012
J of Biomedicine and Biotechnology
Plants provide accurate low-cost alternative for diagnosis of West Nile Virus
Qiang "Shawn" Chen, a researcher at Arizona State University's Biodesign Institute and a professor in the College of Technology and Innovation has developed a new method of testing for West Nile, using plants to produce biological reagents for detection and diagnosis.

Contact: Richard.Harth
Arizona State University

Public Release: 23-Oct-2012
PLOS Medicine
Product regulatory systems in low-and middle-income countries must be strengthened
When regulatory systems for medical products in low-and middle-income countries work, people live but when such systems fail, people die, according to experts from the US Food and Drug Administration writing in this week's PLOS Medicine.

Contact: Sumrina Yousufzai

Public Release: 22-Oct-2012
Proceedings of the National Academy of Sciences
Technology brings new life to the study of diseases in old bones
A study led by The University of Manchester has demonstrated that new technology that can analyze millions of gene sequences in a matter of seconds is an effective way to quickly and accurately identify diseases in skeletons.

Contact: Morwenna Grills
University of Manchester

Public Release: 22-Oct-2012
Proceedings of the National Academy of Sciences
CU-Boulder discoveries hold promise for treatment of Hepatitis B virus
A University of Colorado Boulder-led team has discovered two prime targets of the Hepatitis B virus in liver cells, findings that could lead to treatment of liver disease in some of the 400 million people worldwide currently infected with the virus.
National Institutes of Health

Contact: Ding Xue
University of Colorado at Boulder

Public Release: 19-Oct-2012
Journal of Biological Chemistry
Cholera discovery could revolutionize antibiotic delivery
Three Simon Fraser University scientists are among six researchers who've made a discovery that could help revolutionize antibiotic treatment of deadly bacteria. They have explained how Vibrio cholerae became a deadly pathogen thousands of years ago. Two genes within V. cholerae's genome make it toxic and deadly. The bacterium acquired these genes when a bacterial virus or bacteriophage called CTX-phi infected it. The Journal of Biological Chemistry has just published a paper written by the researchers.

Contact: Carol Thorbes
Simon Fraser University

Public Release: 18-Oct-2012
7th Annual AZBio Awards
TGen's and NAU's Dr. Paul Keim named AZBio's 2012 Bioscience Researcher of the Year
Dr. Paul Keim, Director of the Pathogen Genomics Division of the Translational Genomics Research Institute and the Cowden Endowed Chair of Microbiology at Northern Arizona University, will receive the 2012 Bioscience Researcher of the Year award from the Arizona BioIndustry Association.

Contact: Steve Yozwiak
The Translational Genomics Research Institute

Public Release: 18-Oct-2012
First Africa Regional Conference on Gerontology and Geriatrics
Bristol-Myers Squibb Foundation's SECURE THE FUTUREŽ program announces new findings confirming Grandmothers Against Poverty and AIDS has positive impact on mitigating HIV/AIDS impact in the community
Survey finds empowerment program helps 57 percent of respondents reduce socioeconomic impact of HIV/AIDS by providing tools to reduce poverty and emotional burden of disease.

Contact: Joanna Ritter
CPR Worldwide

Public Release: 17-Oct-2012
Journal of Medicinal Chemistry
New malaria drug requires just one dose and appears twice as effective as existing regimen
Scientists are reporting development of a new malaria drug that, in laboratory tests, has been twice as effective as the best current medicine against this global scourge and may fight off the disease with one dose, instead of the multiple doses that people often fail to take. A report on the drug appears in ACS' Journal of Medicinal Chemistry.

Contact: Michael Bernstein
American Chemical Society

Public Release: 17-Oct-2012
As MDR-TB continues to spread, efforts coordinating TB detection and treatment hold promise
A new partnership announced today will increase efforts to coordinate the development of complementary novel tools to fight TB, including drug-resistant TB, and identify emerging drug resistance trends around the globe.

Contact: Derek Ambrosino
TB Alliance

Public Release: 17-Oct-2012
Science Translational Medicine
Epigenetic analysis of stomach cancer finds new disease subtypes
Researchers at the Duke-NUS Graduate Medical School in Singapore have identified numerous new subtypes of gastric cancer that are triggered by environmental factors.

Contact: Sarah Avery
Duke University Medical Center

Public Release: 16-Oct-2012
UNC-led consortium awarded $4 million to train next generation of global health researchers
The University of North Carolina at Chapel Hill is leading a consortium that will help cultivate the next generation of global health clinicians and scientists, offering a 10-month training fellowship at one of 17 sites in 13 countries in Asia, Africa, and South America.
NIH/Fogarty International Center

Contact: Lisa Chensvold
University of North Carolina Health Care

Public Release: 16-Oct-2012
Biophysical Journal
Novel insights into the physical basis of sickle cell disease could lead to better treatments
Sickle cell disease -- the most common inherited blood disorder in the United States -- causes red blood cells to distort into a crescent shape and block small blood vessels. New insights into how these abnormal cells disrupt circulation could lead to more effective treatment strategies, as revealed by a study published by Cell Press in the Oct. 17 issue of Biophysical Journal.

Contact: Elisabeth (Lisa) Lyons
Cell Press

Public Release: 15-Oct-2012
Proceedings of the National Academy of Sciences
Ebola antibody treatment, produced in plants, protects monkeys from lethal disease
A new Ebola virus study resulting from a widespread scientific collaboration has shown promising preliminary results, preventing disease in infected nonhuman primates using monoclonal antibodies. When treatment was administered one hour after infection, all animals survived. Two-thirds of the animals were protected even when the treatment, known as MB-003, was administered 48 hours after infection.
National Institutes of Health, Defense Advanced Research Projects Agency, Transformational Medical Technologies Initiative, Defense Threat Reduction Agency

Contact: Caree Vander Linden
US Army Medical Research Institute of Infectious Diseases

Public Release: 15-Oct-2012
Urgent need for tuberculosis vaccines; experts report progress, obstacles in growing drug resistance
Drawing on recent findings of a significant rise in cases of drug-resistant tuberculosis in the UK and globally, top TB researchers at a briefing today in London called for greater focus on the quest for new vaccines--a crucial long-term, cost-effective method for addressing the growing threat.

Contact: Coimbra Sirica
Burness Communications

Public Release: 11-Oct-2012
Using cell phone data to curb the spread of malaria
New research that combines cell phone data from 15 million people in Kenya with detailed information on the regional incidence of malaria has revealed how human travel patterns contribute to the disease's spread.
NIH Models of Infectious Disease Agent Study Program, National Science Foundation

Contact: Todd Datz
Harvard School of Public Health

Public Release: 10-Oct-2012
Aeras signs agreement with GSK to jointly advance TB vaccine
Aeras announces that it has signed an agreement with GlaxoSmithKline Vaccines, S.A. (GSK) to jointly advance the clinical development of an investigational tuberculosis (TB) vaccine containing GSK's proprietary M72 antigen and AS01E* adjuvant. This novel research and resource-sharing agreement between the largest non-profit TB vaccine biotech and one of the world's leading research-based pharmaceutical and healthcare companies marks advancement in the race to develop new vaccines against TB, a global infectious disease killer.

Contact: Jamie Rosen

Public Release: 10-Oct-2012
How to address mental disorders in developing countries, 'the most neglected of neglected diseases'
Canadian funding of $19.4 million will support 15 landmark projects to improve mental health diagnosis and care in developing countries: "the most neglected of neglected diseases." Many projects address problems in nations ravaged by conflict and disaster as well as poverty. Of almost 450 million people with mental health disorders, over 75% live in developing countries. WHO estimates 85% of those with serious mental disorders in the developing world receive no treatment at all.

Contact: Terry Collins
Sandra Rotman Centre for Global Health

Showing releases 626-650 out of 901.

<< < 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 > >>